SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,264.51 330.92
( 0.43%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,369.62 237.64
(0.36%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hinduja Global Solutions Ltd

Industry : Computers - Software - Medium / Small

BSE Code

ISIN Demat

Book Value()

532859

INE170I01016

555.2739595

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HGS

1871.05

EPS(TTM)

Face Value()

Div & Yield %

1.24

Back

nouveau global ventures ltd

Lupin receives USFDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg

Aug 17,2026

Lupin has received the final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg.

The U.S. FDA has approved Lupin's Pitolisant Tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix® for the indications in the approved labeling.

77,264.51 330.92 ( 0.43%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,369.62 237.64 (0.36%)

10,816.31 23.77 (0.22%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)